Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

This hybrid position is based in Waltham MA, King of Prussia PA, Glattburg Switzerland, or Maidenhead UK, and is onsite three days a week.

• Serve as the senior Search & Evaluation leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning.
• Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with therapeutic area strategy and unmet medical needs.
• Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL therapeutic area.
• Engage extensively with external Key Opinion Leaders (KOLs), clinical investigators, and networks to validate asset potential, understand trial designs and clinical endpoints, and anticipate competitive dynamics.
• Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy.
• Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions.
• Partner closely with Business Development and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution.
• Represent the therapeutic area externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities.